Episode Details
Back to Episodes
Bispecific Antibodies in the Management of Multiple Myeloma
Season 1
Published 1 year, 9 months ago
Description
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
CME information and select publications here.